Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report

Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report

A 35-year-old man with a late-onset combined immunodeficiency (LOCID) variant of common variable immunodeficiency, severe plaque psoriasis, psoriatic arthritis, and Crohn’s disease was attended in the Regional Hospital of Presidente Prudente and HC-FMUSP, São Paulo, Brazil. Anti-IL-12/IL-23 (ustekin...

Full description

Bibliographic Details
Main Authors: Luiz Euribel Prestes-Carneiro, Marilda Aparecida Milanez Morgado de Abreu, Eduardo Vinicius Mendes Roncada, Diego Garcia Muchon, Fernanda Miranda Caliani, Dewton Moraes Vasconcelos
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Pathogens
Subjects:
late-onset combined immunodeficiency
psoriasis
ustekinumab
infections
Online Access:https://www.mdpi.com/2076-0817/12/9/1156

Internet

https://www.mdpi.com/2076-0817/12/9/1156

Similar Items